Skip to content

Non-invasive Nerve Stimulation and Sleep

Transcutaneous Vagal Nerve Stimulation Improvement of Sleep Quality in Veterans With PTSD With or Without History of Mild TBI

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04021537
Acronym
NINS
Enrollment
87
Registered
2019-07-16
Start date
2020-01-30
Completion date
2026-10-01
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

PTSD

Brief summary

People often have difficulty sleeping. Reasons are many. But, difficulty falling and staying asleep are common issues. Sleep difficulties are common in disorders such as Post Traumatic Stress Disorder. Current treatments for sleep difficulties are not effective for everyone. Better treatments are needed. In this study, the investigators are testing two nerve stimulation locations that may impact brain function in such a way that sleep is improved.

Detailed description

People often have difficulty sleeping. Reasons are many. But, difficulty falling and staying asleep are common issues. Sleep difficulties are common in disorders such as Post Traumatic Stress Disorder. Current treatments for sleep difficulties are not effective for everyone. Better treatments are needed. In this study, the investigators are testing two nerve stimulation locations that may impact brain function in such a way that sleep is improved. Prior to the cross-over study described here, a dosing study will be completed. Twenty Veterans with PTSD with or without history of mTBI, assessed for inclusion and exclusion per protocol, will be evaluated over three polysomnography nights with at least a one week washout period. Pseudo-randomly distributed across the three nights, each participant will be tested on three of the 10 parameters, creating a total of 60 testing sessions (6 for each parameter setting with each represented twice in each night slot). primary sleep architecture variables (slow wave sleep time, REM sleep time) and autonomic responses will be used as outcomes. The optimal dose will be selected and the study will proceed to the cross-over design phase.

Interventions

DEVICEnon-invasive nerve stimulation

Electrical stimulation will be provided via a TENS unit.

Sponsors

VA Office of Research and Development
Lead SponsorFED

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Investigator)

Intervention model description

The study is a cross-over design comparing two stimulation types. The order of stimulation is randomly assigned. Note, there is also a dosing study. Enrollment includes the dosing study (21 participants, 3 nights each). crossover enrollment = 66

Eligibility

Sex/Gender
ALL
Age
18 Years to 55 Years
Healthy volunteers
Yes

Inclusion criteria

* Condition: Hx VA/DOD criteria PTSD w or w/o mTBI and current sig symptoms of PTSD * English fluency

Exclusion criteria

* Neurological injuries or conditions aside from mTBI that may affect outcome variables and/or other variables in the study * Psychiatric issues that are unlikely to be related to trauma that may affect outcomes and/or other variables in the * e.g., schizophrenia * Untreated sleep apnea * CPAP controlled sleep apnea is okay * Major uncorrected sensory deficit * Current drug or alcohol abuse * Drug abuse within the last two months will result in exclusion or delay * Marijuana use or alcohol intoxication within 2 weeks of study will be acceptable * No pregnancy

Design outcomes

Primary

MeasureTime frameDescription
PolysomnographyOne night comparisonPolysomnography measures. Slow wave sleep time. Rem sleep time.

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORJohn B. Williamson, PhD

North Florida/South Georgia Veterans Health System, Gainesville, FL

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 3, 2026